FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138808833> ?p ?o ?g. }

• W2138808833 endingPage "37" @default.
• W2138808833 startingPage "30" @default.
• W2138808833 abstract "Purpose. The purpose of this study was to describe the feasibility of a combined preoperative chemoradiation program followed by radical surgery in advanced cervical cancer. Materials and methods. From February 1988 to April 1997, 40 patients with carcinoma of the cervix were treated with preoperative external beam radiotherapy to 45 Gy in 5 weeks. Patients received concurrent continuous infusion cisplatin (20 mg/m2) and 5-fluorouracil (1500 mg) chemotherapy during the first (days 1–4) and fifth (days 22–25) weeks of the radiation course. Radical surgery was performed 4–6 weeks after the completion of the preoperative treatment. Intraoperative radiotherapy was given to 20 patients, based on intraoperative assessment. Results. Toxicity associated with chemoradiation was usually mild except in two patients who presented WHO grade 4 bone marrow aplasia. Three patients developed postoperative ureterovaginal fistula, and five patients developed long-term hydronephrosis that needed ureteral stenting. Clinical response was observed in 95% of the patients (55% complete response). The analysis of the surgical specimens revealed complete pathological response in 67.5% of the cases and partial pathological response in 32.5%. As expected, the degree of pathological response was predicted by the degree of clinical response (P = 0.001). Nine-year local control, distant metastases-free survival, disease-free survival, and overall survival were 86, 84, 81, and 85%, respectively. Patients displaying a complete pathological response had statistically significant improved local control (P = 0.004), distant metastases-free survival (P = 0.009), disease-free survival (P = 0.002), and overall survival (P = 0.038). Conclusions. Cisplatin plus 5-fluorouracil preoperative chemoradiation is active and usually well tolerated in locally advanced carcinoma of cervix, inducing a high rate of clinical and pathological complete responses. When this therapy is followed by radical surgery, the local control rates are excellent, even in patients with advanced stages or poor response. These improved local control rates may be achievable only through extensive surgical resection, with a parallel increase in the complication rates." @default.
• W2138808833 created "2016-06-24" @default.
• W2138808833 creator A5000287013 @default.
• W2138808833 creator A5020099657 @default.
• W2138808833 creator A5021003281 @default.
• W2138808833 creator A5022287984 @default.
• W2138808833 creator A5042786845 @default.
• W2138808833 creator A5048323398 @default.
• W2138808833 creator A5052881615 @default.
• W2138808833 date "1999-07-01" @default.
• W2138808833 modified "2023-10-18" @default.
• W2138808833 title "Pilot Study of Concurrent Cisplatin, 5-Fluorouracil, and External Beam Radiotherapy Prior to Radical Surgery +/− Intraoperative Electron Beam Radiotherapy in Locally Advanced Cervical Cancer" @default.
• W2138808833 cites W1926137745 @default.
• W2138808833 cites W1975276234 @default.
• W2138808833 cites W1985324368 @default.
• W2138808833 cites W1988493626 @default.
• W2138808833 cites W1990272165 @default.
• W2138808833 cites W1990358773 @default.
• W2138808833 cites W1993717128 @default.
• W2138808833 cites W1995170578 @default.
• W2138808833 cites W2010004581 @default.
• W2138808833 cites W2014350311 @default.
• W2138808833 cites W2020434147 @default.
• W2138808833 cites W2026800428 @default.
• W2138808833 cites W2027040462 @default.
• W2138808833 cites W2036940815 @default.
• W2138808833 cites W2041572496 @default.
• W2138808833 cites W2044412743 @default.
• W2138808833 cites W2045842425 @default.
• W2138808833 cites W2054294648 @default.
• W2138808833 cites W2056559030 @default.
• W2138808833 cites W2077349462 @default.
• W2138808833 cites W2080063001 @default.
• W2138808833 cites W2086074968 @default.
• W2138808833 cites W2113251111 @default.
• W2138808833 cites W2119622933 @default.
• W2138808833 cites W2120405223 @default.
• W2138808833 cites W2142886194 @default.
• W2138808833 cites W2144462803 @default.
• W2138808833 cites W2159878950 @default.
• W2138808833 cites W2278556698 @default.
• W2138808833 doi "https://doi.org/10.1006/gyno.1999.5424" @default.
• W2138808833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10385548" @default.
• W2138808833 hasPublicationYear "1999" @default.
• W2138808833 type Work @default.
• W2138808833 sameAs 2138808833 @default.
• W2138808833 citedByCount "68" @default.
• W2138808833 countsByYear W21388088332012 @default.
• W2138808833 countsByYear W21388088332013 @default.
• W2138808833 countsByYear W21388088332014 @default.
• W2138808833 countsByYear W21388088332015 @default.
• W2138808833 countsByYear W21388088332016 @default.
• W2138808833 countsByYear W21388088332017 @default.
• W2138808833 countsByYear W21388088332018 @default.
• W2138808833 countsByYear W21388088332020 @default.
• W2138808833 countsByYear W21388088332021 @default.
• W2138808833 countsByYear W21388088332023 @default.
• W2138808833 crossrefType "journal-article" @default.
• W2138808833 hasAuthorship W2138808833A5000287013 @default.
• W2138808833 hasAuthorship W2138808833A5020099657 @default.
• W2138808833 hasAuthorship W2138808833A5021003281 @default.
• W2138808833 hasAuthorship W2138808833A5022287984 @default.
• W2138808833 hasAuthorship W2138808833A5042786845 @default.
• W2138808833 hasAuthorship W2138808833A5048323398 @default.
• W2138808833 hasAuthorship W2138808833A5052881615 @default.
• W2138808833 hasConcept C121608353 @default.
• W2138808833 hasConcept C126322002 @default.
• W2138808833 hasConcept C126894567 @default.
• W2138808833 hasConcept C141071460 @default.
• W2138808833 hasConcept C207886595 @default.
• W2138808833 hasConcept C2775908122 @default.
• W2138808833 hasConcept C2776694085 @default.
• W2138808833 hasConcept C2776874909 @default.
• W2138808833 hasConcept C2777416452 @default.
• W2138808833 hasConcept C2778220009 @default.
• W2138808833 hasConcept C2780456651 @default.
• W2138808833 hasConcept C509974204 @default.
• W2138808833 hasConcept C71924100 @default.
• W2138808833 hasConceptScore W2138808833C121608353 @default.
• W2138808833 hasConceptScore W2138808833C126322002 @default.
• W2138808833 hasConceptScore W2138808833C126894567 @default.
• W2138808833 hasConceptScore W2138808833C141071460 @default.
• W2138808833 hasConceptScore W2138808833C207886595 @default.
• W2138808833 hasConceptScore W2138808833C2775908122 @default.
• W2138808833 hasConceptScore W2138808833C2776694085 @default.
• W2138808833 hasConceptScore W2138808833C2776874909 @default.
• W2138808833 hasConceptScore W2138808833C2777416452 @default.
• W2138808833 hasConceptScore W2138808833C2778220009 @default.
• W2138808833 hasConceptScore W2138808833C2780456651 @default.
• W2138808833 hasConceptScore W2138808833C509974204 @default.
• W2138808833 hasConceptScore W2138808833C71924100 @default.
• W2138808833 hasIssue "1" @default.
• W2138808833 hasLocation W21388088331 @default.
• W2138808833 hasLocation W21388088332 @default.
• W2138808833 hasOpenAccess W2138808833 @default.
• W2138808833 hasPrimaryLocation W21388088331 @default.
• W2138808833 hasRelatedWork W2379629551 @default.
• W2138808833 hasRelatedWork W2384708512 @default.

• next